Aurobindo Pharma (AUROPHARMA.NS) Financial Analysis & Valuation | Quarter Chart
Aurobindo Pharma (AUROPHARMA.NS)
AUROPHARMA.NSPrice: $12.67
Fair Value: 🔒
🔒score
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingre... more
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharm... more
Description
Shares
| Market Cap | $7.36B | Exchange | NSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | IN | CEO | Makkapati Satakarni |
| IPO Date | 1996-01-15 | CAGR | 0.16% |
| Employees | 26,015 | Website | www.aurobindo.com |
| Div. Yield | 0.31% | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | 0.31% |
AUROPHARMA.NS chart loading...
Fundamentals
Technicals
| Enterprise Value | $659.22B | P/E Ratio | 19.06 |
| Forward P/E | 18.2 | PEG Ratio | 3.04 |
| P/S Ratio | 2.43 | P/B Ratio | 2.38 |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $0.66 | EPS Growth 1Y | -2.91% |
| EPS Growth 3Y | 42.52% | EPS Growth 5Y | 14.31% |
| Revenue Growth 1Y | 7.76% | Gross Margin | 0.58% |
| Operating Margin | 0.23% | Profit Margin | 0.11% |
| ROE | 0.11% | ROA | — |
| ROCE | — | Current Ratio | — |
| Quick Ratio | — | Cash Ratio | — |
| Debt/Equity | — | Interest Coverage | 16.63 |
| Altman Z Score | — | Piotroski Score | 3 |